Natera

-$1.68 (-1.59%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Natera and other stocks, options, and ETFs commission-free!

About NTRA

Natera, Inc. Common Stock, also called Natera, is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services.

CEO

Stephen Chapman

Employees

1,815

Headquarters

Austin, Texas

Founded

2003

NTRA Key Statistics

Market Cap

9.14B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

947.22K

High Today

$106.42

Low Today

$102.75

Open Price

$105.61

Volume

1.06M

52 Week High

$127.19

52 Week Low

$39.43

NTRA News

ABC NewsJun 10

Cutting-edge test detects early tumor recurrence in some cancers

A new blood test seeks to change the game in cancer management. Signatera, a "tumor-informed" blood test developed by Natera, can detect circulating tumor DNA

Analyst Ratings

100%

of 11 ratings

Buy

100%

Hold

Sell

NTRA Earnings

-$1.02

-$0.68

-$0.34

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 4, After Hours